AU5104696A - A method for identifying a novel multidrug-resistance type - Google Patents

A method for identifying a novel multidrug-resistance type

Info

Publication number
AU5104696A
AU5104696A AU51046/96A AU5104696A AU5104696A AU 5104696 A AU5104696 A AU 5104696A AU 51046/96 A AU51046/96 A AU 51046/96A AU 5104696 A AU5104696 A AU 5104696A AU 5104696 A AU5104696 A AU 5104696A
Authority
AU
Australia
Prior art keywords
identifying
resistance type
novel multidrug
multidrug
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51046/96A
Inventor
George Lodewijk Scheffer
Riekeld Johannes Scheper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU5104696A publication Critical patent/AU5104696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
AU51046/96A 1995-03-06 1996-03-06 A method for identifying a novel multidrug-resistance type Abandoned AU5104696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200543 1995-03-06
EP95200543 1995-03-06
PCT/EP1996/001013 WO1996027611A1 (en) 1995-03-06 1996-03-06 A method for identifying a novel multidrug-resistance type

Publications (1)

Publication Number Publication Date
AU5104696A true AU5104696A (en) 1996-09-23

Family

ID=8220068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51046/96A Abandoned AU5104696A (en) 1995-03-06 1996-03-06 A method for identifying a novel multidrug-resistance type

Country Status (2)

Country Link
AU (1) AU5104696A (en)
WO (1) WO1996027611A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002523015A (en) * 1998-03-27 2002-07-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Human vault RNA
US6156879A (en) * 1998-06-03 2000-12-05 The Regents Of The University Of California Human minor vault protein p193
WO2001055455A2 (en) * 2000-01-31 2001-08-02 Millennium Pharmaceuticals, Inc. Resistance sequences and uses thereof
CN112724253B (en) * 2021-03-09 2022-04-05 生工生物工程（上海）股份有限公司 Antibody of anti-human vault protein and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO881560L (en) * 1987-05-05 1988-11-07 Hope City PROCEDURE FOR DETECTING BEGINNING RESISTANCE OF MOTHERAPEUTIC AGENTS IN CANCER PATIENTS.
JP3240304B2 (en) * 1991-09-04 2001-12-17 独立行政法人産業技術総合研究所 Stabilized ribozyme

Also Published As

Publication number Publication date
WO1996027611A1 (en) 1996-09-12

Similar Documents

Publication Publication Date Title
GB9518871D0 (en) Bridge for a client server-environment
AU4973396A (en) A method for making heteromultimeric polypeptides
AU3721195A (en) A speech interface for an automated endoscopic system
AU3903995A (en) A combustion apparatus
AU6131796A (en) Anticounterfeiting method
AU5936596A (en) Can collection apparatus
AU6904196A (en) A valvulotome
AU4468496A (en) A method for predicting protein structure
AU5104696A (en) A method for identifying a novel multidrug-resistance type
AU695875B2 (en) A method for washing immunoassay elements
AU4587496A (en) A telecommunications method
AU1723599A (en) A method for identifying new anti-picornaviral compounds
AU1046697A (en) A single-pill-dispenser for lids
AUPN633595A0 (en) A tool
AU7139596A (en) A monitoring system
AU5271296A (en) Novel method
AU1422697A (en) Method for harvesting a protein
AU1101797A (en) Method for making fluoroalkanols
AU6943096A (en) Pressor for rectum-intestine
AU1138397A (en) Novel method
AU6826796A (en) Identification apparatus
AU7004396A (en) A method for flocking
AU6670894A (en) Method for preparing a metal-radionuclide-labelled protein
AU4379196A (en) Process for detecting geopathogenic areas
AU5485596A (en) Process for making 1-hydroxybisphosphonates